Will These 5 Big Drug Stocks Surpass Q4 Earnings Forecasts?

The fourth-quarter earnings season for the drug and biotech sector will be in full swing this week with many large drugmakers like — Merck (MRK) , Pfizer (PFE) , Eli Lilly and Company (LLY) , Amgen (AMGN) and Bristol Myers Squibb (BMY) — due to announce results. Johnson & Johnson and AbbVie have already reported with both beating estimates for both earnings and sales. French drugmaker Sanofi came out with disappointing fourth-quarter results as it missed estimates for both earnings and sales.Find the latest ...